Cancer is so often an agonizing diagnosis, one that can be that much more difficult for a patient to accept when the origin of the cancer cannot be traced. Novel genetic tests are just one of a few new options that may help us in situations where imaging, therapy, and other genetic markers have not been effective. Dr. F. Anthony Greco, director of the Sarah Cannon Cancer Center in Nashville, tells us that we appear to be making progress toward new ways to diagnose cancers of unknown primary origin. Dr. Larry Kaskel hosts.
Testing to Trace Cancers of Unknown Primary Origin
Share this program on:
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Details
Presenters
Recommended
Details
Presenters
Overview
Cancer is so often an agonizing diagnosis, one that can be that much more difficult for a patient to accept when the origin of the cancer cannot be traced. Novel genetic tests are just one of a few new options that may help us in situations where imaging, therapy, and other genetic markers have not been effective. Dr. F. Anthony Greco, director of the Sarah Cannon Cancer Center in Nashville, tells us that we appear to be making progress toward new ways to diagnose cancers of unknown primary origin. Dr. Larry Kaskel hosts.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
MinuteCE®
M3: Managing the Cardiometabolic Risk in MASH
1.00 credits
<p><span data-contrast="auto" xml:lang="EN-US">M3: Managing the Cardiometabolic Risk in MASH</span><span data-ccp-props='{"201341983":0,"335559739":160,"335559740":259}'> </span></p>
MinuteCE®
Don’t Wait to Escalate—Getting Aggressive in PH Management
1.00 credits
<p>Don’t Wait to Escalate—Getting Aggressive in PH Management</p>
MinuteCE®
Finding the Patient With PH Among Us: How We Optimize Treatment Based on Patient Type
1.00 credits
<p><span data-contrast="none" xml:lang="EN-US">Finding the Patient With PH Among Us: How We Optimize Treatment Based on Patient Type</span> </p>
Perspectives with the AMA
Implementing the AMA MAPTM Hypertension Program: A Clinician’s Experience
<p>Implementing the AMA MAP™ Hypertension Program: A Clinician's Experience</p>
MinuteCE®
Application of guidelines-recommended broad molecular profiling to patients with NSCLC
1.00 credits
<p>Application of guidelines-recommended broad molecular profiling to patients with NSCLC</p>
MinuteCE®
Guideline Considerations for Immunotherapy in Primary Advanced or Recurrent Endometrial Cancer
1.00 credits
<p>Guideline Considerations for Immunotherapy in Primary Advanced or Recurrent Endometrial Cancer</p>
CME/CE
Impact of Barostim on Heart Failure Hospitalization
<p>Impact of Barostim on Heart Failure Hospitalization</p>
NeuroFrontiers
Navigating Myasthenia Gravis in Adolescents and Young Adults
<p>Navigating Myasthenia Gravis in Adolescents and Young Adults</p>
Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?